NEW YORK (GenomeWeb) – Paradigm Diagnostics said today that it has closed a $15 million Series B fundraising, which has been ongoing since 2017. In conjunction with the closing, the firm has added Mara Aspinall, managing director of BlueStone Venture Partners, to its board of directors.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.